Course overview
Dawn of the Era of Treatable Alzheimer’s Disease
In this course, review opportunities that exist to improve our cognition regardless of if mild cognitive impairment (MCI) and subjective cognitive impairment (SCI), conditions - that can be precursors to Alzheimer’s disease - are present.
Faculty
Dale Bredesen, MD
Board Review Series
AIHM 2018 Annual Conference
Required Lessons
1
Time to Complete
1 hour
Non-CME Eligible*
0 Credits
What you will learn
-
Course Summary
-
By the end of this course, learners will be able to:
- Identify the subtypes of Alzheimer’s disease
- Evaluate patients with dementia or dementia risk
- Recognize how to treat patients with Alzheimer’s or pre-Alzheimer’s effectively
Course includes:
Included in this course
Course Faculty
Dale Bredesen, MD
About Dale
Dale E. Bredesen, MD, is internationally recognized as an expert in the mechanisms of neurodegenerative diseases such as Alzheimer’s disease. He graduated from Caltech then earned his MD from Duke University Medical Center in Durham, North Carolina. He served as chief resident in neurology at the University of California, San Francisco (UCSF) before joining Nobel Laureate Stanley Prusiner’s laboratory at UCSF as a National Institutes of Health postdoctoral fellow. He has held faculty positions at UCSF; the University of California, Los Angeles; and the University of California, San Diego. Dr Bredesen directed the Program on Aging at the Burnham Institute before coming to the Buck Institute in 1998 as its founding president and CEO.
*CME/CEU Credits
The CME for this course has expired, however you will continue to have access to your purchased content.